gabelli healthcare & wellness tr - GRX
GRX
Close Chg Chg %
9.64 0.11 1.13%
Closed Market
9.75
+0.11 (1.13%)
Volume: 37.53K
Last Updated:
Feb 6, 2026, 3:59 PM EDT
Company Overview: gabelli healthcare & wellness tr - GRX
GRX Key Data
| Open $9.64 | Day Range 9.64 - 9.75 |
| 52 Week Range 8.93 - 10.24 | Market Cap $152.47M |
| Shares Outstanding 15.80M | Public Float 15.53M |
| Beta 0.90 | Rev. Per Employee N/A |
| P/E Ratio N/A | EPS N/A |
| Yield 685.36% | Dividend $0.17 |
| EX-DIVIDEND DATE Dec 12, 2025 | SHORT INTEREST N/A |
| AVERAGE VOLUME 36.33K |
GRX Performance
| 1 Week | 0.16% | ||
| 1 Month | -1.23% | ||
| 3 Months | 4.76% | ||
| 1 Year | -5.22% | ||
| 5 Years | -21.64% |
GRX Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
Full Ratings ➔
An error occurred while fetching the data.
An error occurred while fetching the data.
An error occurred while fetching the data.
SEC Filings for Gabelli Healthcare & Wellness Tr - GRX
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Gabelli Healthcare & Wellness Tr - GRX
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Jan 13, 2026 | Gabelli & Company Investment Advisers, Inc. Director | 8,990 | Open market or private purchase of non-derivative security Non-derivative transaction at $9.58 per share | 86,124.20 |
| Dec 5, 2025 | Mario Joseph Gabelli Director | 239,425 | Open market or private purchase of non-derivative security Non-derivative transaction at $9.69 per share | 2,320,028.25 |
| Dec 3, 2025 | Anthonie C. van Ekris Director | 9,185 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $9.12 per share | 83,767.20 |
| Dec 3, 2025 | Anthonie C. van Ekris Director | 7,185 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $9.2 per share | 66,102.00 |
| Dec 3, 2025 | Anthonie C. van Ekris Director | 6,985 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $9.5 per share | 66,357.50 |
| Dec 3, 2025 | Anthonie C. van Ekris Director | 6,185 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $9.5 per share | 58,757.50 |
| Dec 3, 2025 | Anthonie C. van Ekris Director | 5,185 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $9.26 per share | 48,013.10 |
| Dec 3, 2025 | Anthonie C. van Ekris Director | 4,185 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $9.27 per share | 38,794.95 |
| Dec 3, 2025 | Anthonie C. van Ekris Director | 3,185 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $9.15 per share | 29,142.75 |
| Dec 3, 2025 | Anthonie C. van Ekris Director | 2,185 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $9.12 per share | 19,927.20 |
| Oct 24, 2025 | Saba Capital Management LP | 2,066,493 | Open market or private purchase of non-derivative security Non-derivative transaction at $9.29 per share | 19,197,719.97 |
| Oct 24, 2025 | Saba Capital Management LP | 2,067,546 | Open market or private purchase of non-derivative security Non-derivative transaction at $9.31 per share | 19,248,853.26 |